Platelet Aggregation Inhibitors
"Platelet Aggregation Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
| Descriptor ID |
D010975
|
| MeSH Number(s) |
D27.505.954.502.780
|
| Concept/Terms |
Platelet Aggregation Inhibitors- Platelet Aggregation Inhibitors
- Aggregation Inhibitors, Platelet
- Inhibitors, Platelet Aggregation
- Blood Platelet Antiaggregants
- Antiaggregants, Blood Platelet
- Platelet Antiaggregants
- Antiaggregants, Platelet
- Blood Platelet Aggregation Inhibitors
Antiplatelet Agents- Antiplatelet Agents
- Agents, Antiplatelet
- Antiplatelet Drugs
- Drugs, Antiplatelet
Platelet Antagonists- Platelet Antagonists
- Antagonists, Platelet
- Blood Platelet Antagonists
- Antagonists, Blood Platelet
|
Below are MeSH descriptors whose meaning is more general than "Platelet Aggregation Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Platelet Aggregation Inhibitors".
This graph shows the total number of publications written about "Platelet Aggregation Inhibitors" by people in this website by year, and whether "Platelet Aggregation Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 0 | 4 | 4 |
| 2000 | 1 | 2 | 3 |
| 2001 | 2 | 1 | 3 |
| 2002 | 2 | 4 | 6 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 1 | 4 |
| 2005 | 3 | 2 | 5 |
| 2006 | 4 | 1 | 5 |
| 2007 | 2 | 2 | 4 |
| 2008 | 4 | 3 | 7 |
| 2009 | 4 | 6 | 10 |
| 2010 | 3 | 2 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 4 | 3 | 7 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 0 | 3 |
| 2015 | 6 | 4 | 10 |
| 2016 | 10 | 7 | 17 |
| 2017 | 6 | 7 | 13 |
| 2018 | 14 | 2 | 16 |
| 2019 | 9 | 7 | 16 |
| 2020 | 7 | 4 | 11 |
| 2021 | 6 | 5 | 11 |
| 2022 | 5 | 7 | 12 |
| 2023 | 0 | 4 | 4 |
| 2024 | 7 | 3 | 10 |
| 2025 | 4 | 1 | 5 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Platelet Aggregation Inhibitors" by people in Profiles.
-
Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association. Stroke. 2026 Aug; 57(8):e437-e454.
-
Platelet inhibition delays time to neurosurgical intervention for cerebral metastasis in non-small cell lung cancer. Sci Rep. 2025 Nov 04; 15(1):38467.
-
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial. J Am Coll Cardiol. 2025 Apr 01; 85(12):1317-1331.
-
Impact of desmopressin on hematoma expansion in patients presenting to the emergency department on antiplatelet therapy. Am J Emerg Med. 2025 07; 93:126-131.
-
Impact of Perioperative Anticoagulation and Antiplatelet Therapy on Hearing Preservation Outcomes. Otol Neurotol. 2025 02 01; 46(2):128-132.
-
Efficacy and safety of mechanical thrombectomy in distal medium middle cerebral artery occlusion ischemic stroke patients on low-dose aspirin. Int J Stroke. 2025 07; 20(6):669-678.
-
A Multicenter Evaluation of Clopidogrel Resistance and Its Role in Predicting Stent Thrombosis in Transcarotid Artery Revascularization. Ann Vasc Surg. 2025 Jan; 110(Pt A):226-232.
-
Abbreviated ticagrelor based dual antiplatelet therapy in acute coronary syndrome: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 06; 75:64-70.
-
Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians. Expert Rev Cardiovasc Ther. 2024 Sep; 22(9):483-491.
-
Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention. Pharmacogenomics. 2024; 25(7):293-298.